Journal
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
Volume 103, Issue 12, Pages 3907-3918Publisher
WILEY
DOI: 10.1002/jbm.a.35512
Keywords
biodegradable hydrogel; antimicrobial peptide; factorial analysis; wound healing; formulation
Funding
- Norman Hackerman Advanced Research Program (ARP)
- National Institutes of Health [HL 118498, EB 012575, CA 182670]
- National Science Foundation [DMR 1313553, CMMI 1266116]
- Direct For Mathematical & Physical Scien
- Division Of Materials Research [1313553] Funding Source: National Science Foundation
Ask authors/readers for more resources
Wound healing is usually facilitated by the use of a wound dressing that can be easily applied to cover the wound bed, maintain moisture, and avoid bacterial infection. In order to meet all of these requirements, we developed an in situ forming biodegradable hydrogel (iFBH) system composed of a newly developed combination of biodegradable poly(ethylene glycol) maleate citrate (PEGMC) and poly(ethylene glycol) diacrylate (PEGDA). The in situ forming hydrogel systems are able to conform to the wound shape in order to cover the wound completely and prevent bacterial invasion. A 2(k) factorial analysis was performed to examine the effects of polymer composition on specific properties, including the curing time, Young's modulus, swelling ratio, and degradation rate. An optimized iFBH formulation was achieved from the systematic factorial analysis. Further, in vitro biocompatibility studies using adult human dermal fibroblasts (HDFs) confirmed that the hydrogels and degradation products are not cytotoxic. The iFBH wound dressing was conjugated and functionalized with antimicrobial peptides as well. Evaluation against bacteria both in vitro and in vivo in rats demonstrated that the peptide-incorporated iFBH wound dressing offered excellent bacteria inhibition and promoted wound healing. These studies indicated that our in situ forming antimicrobial biodegradable hydrogel system is a promising candidate for wound treatment. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 3907-3918, 2015.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available